| Health / Medical Topics |
Gantenerumab
A monoclonal antibody against beta-amyloid (Abeta40/42) used in the treatment of Alzheimer's disease. Gantenerumab targets and binds to beta amyloid then is removed through effector cell-mediated clearance. This reduces the level of beta amyloid in the brain. In Alzheimer's disease, beta amyloid accumulates in the brain and is a key component in plaque formation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A recombinant, fully human monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Ganitumab binds to…
The acetate salt form of ganirelix, a synthetic decapeptide with high antagonistic activity against naturally occurring gonadotropin-releasing hormone (GnRH). Ganirelix directly competes…
Gangrene of the mucous membranes of the mouth leading to ulcers and destruction of the soft tissues of the face and…
Death of tissue, usually in considerable mass and generally associated with loss of vascular (nutritive) supply and followed by bacterial invasion and…
A sialoglycosphingolipid that is a branched nonasaccharide containing five sialyl residues, two galactose residues, one N-acetylgalactosamine residue and a glucose residue. This…
A glycosphingolipid antigen expressed by a variety of human cancer cells. GM2 containing vaccines have been shown to elicit antibodies production in…
